Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy Adults

NCT01689259 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adults

Interventions

DRUG: SL TNX-102 at 2.4 mg
DRUG: SL TNX-102 at 4.8 mg
DRUG: SL TNX-102-A at 2.4 mg
DRUG: Cyclobenzaprine tablets

Sponsor

Tonix Pharmaceuticals, Inc.